Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Autoimmune Disorders

Free Subscription Articles published in J Neuroimmunol Retrieve available abstracts of 199 articles: HTML format Text format

Single Articles

February 2010
1. KAIDA K , Kusunoki S
   Antibodies to gangliosides and ganglioside complexes in Guillain-Barre syndrome and Fisher syndrome: Mini-review.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. DOBSON R , Miller RF, Palmer HE, Feldmann M, et al
   Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. KARUSSIS D , Teitelbaum D, Sicsic C, Brenner T, et al
   Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. YATES MA , Li Y, Chlebeck P, Proctor T, et al
   Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. PIAZZA F , Difrancesco JC, Fusco ML, Corti D, et al
   Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. ESPOSITO M , Ruffini F, Bellone M, Gagliani N, et al
   Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. O'BRIEN K , Fitzgerald D, Rostami A, Gran B, et al
   The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
8. BRYNEDAL B , Wojcik J, Esposito F, Debailleul V, et al
   MGAT5 alters the severity of multiple sclerosis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. LIU YM , Liu XJ, Bai SS, Mu LL, et al
   The effect of electroacupuncture on T cell responses in rats with experimental autoimmune encephalitis.
   J Neuroimmunol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. BERGAMASCHI L , Ban M, Leone MA, Sawcer SJ, et al
    No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SUGAWARA M , Wada C, Okawa S, Kobayashi M, et al
    Long-term follow up of thymus in patients with myasthenia gravis.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. LUNEMANN JD , Tackenberg B, Stein A, Wandinger KP, et al
    Dysregulated Epstein-Barr virus infection in patients with CIDP.
    J Neuroimmunol. 2010;218.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ALDINUCCI A , Biagioli T, Manuelli C, Repice AM, et al
    Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP.
    J Neuroimmunol. 2010;218.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. JURYNCZYK M , Selmaj K
    Notch: a new player in MS mechanisms.
    J Neuroimmunol. 2010;218.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. MIZRACHI K , Aricha R, Feferman T, Kela-Madar N, et al
    Involvement of phosphodiesterases in autoimmune diseases.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. NIKODEMOVA M , Lee J, Fabry Z, Duncan ID, et al
    Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ARNETH BM
    Protective autoimmunity and protein localization.
    J Neuroimmunol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
18. MOSTAFA GA , El-Hadidi ES, Hewedi DH, Abdou MM, et al
    Oxidative stress in Egyptian children with autism: relation to autoimmunity.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. BEGUM-HAQUE S , Sharma A, Christy M, Lentini T, et al
    Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. XIA RH , Yosef N, Ubogu EE
    Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barre syndrome.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. DU S , Sandoval F, Trinh P, Voskuhl RR, et al
    Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. WU JS , James I, Qiu W, Castley A, et al
    HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. MARNETTO F , Hellias B, Granieri L, Frau J, et al
    Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica.
    J Neuroimmunol. 2009;217.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. VAN EDEN W
    Protective and therapeutic effect of triptolide in EAE explained by induction of major stress protein HSP70.
    J Neuroimmunol. 2009;217.
    PubMed     Text format     Related articles   
    
    
    
25. MASSILAMANY C , Steffen D, Reddy J
    An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. KIMURA A , Sakurai T, Koumura A, Yamada M, et al
    High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
27. MILLER A , Souroujon MC, Aloisi F
    Translational neuroimmunology: a joint meeting of the Israel Society of Neuroimmunology and the Italian Neuroimmunology Association. Conference review.
    J Neuroimmunol. 2009;216.
    PubMed     Text format     Related articles   
    
    
    
28. PROVENZANO C , Marino M, Scuderi F, Evoli A, et al
    Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. NAMDAR A , Nikbin B, Ghabaee M, Bayati A, et al
    Effect of IFN-ss therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): A preliminary study.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. GANDHI R , Laroni A, Weiner HL
    Role of the innate immune system in the pathogenesis of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. SAWAI S , Umemura H, Mori M, Satoh M, et al
    Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: Proteomic analysis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. YOKOTA SI , Chiba S, Furuyama H, Fujii N, et al
    Cerebrospinal fluids containing anti-HSP70 autoantibodies from multiple sclerosis patients augment HSP70-induced proinflammatory cytokine production in monocytic cells.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. WILLIAMS S , Sakic B, Hoffman SA
    Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. NYATI KK , Prasad KN, Verma A, Singh AK, et al
    Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barre syndrome in Northern Indian population.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. VON BUDINGEN HC , Gulati M, Kuenzle S, Fischer K, et al
    Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands"
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
36. RANGANATHAN P , Chen H, Adelman MK, Schluter SF, et al
    Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. BRETTSCHNEIDER J , Jaskowski TD, Tumani H, Abdul S, et al
    Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. HAGHIKIA A , Gold R
    Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
39. HUANG S , Li L, Liang S, Wang W, et al
    Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barre syndrome.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. BLAES F
    Tumour-induced anti-Hu autoimmunity in mice - A step towards animal models of paraneoplastic disease.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
41. ZARIF YEGANEH M , Ghaffarpour M, Farhud DD, Karimlou M, et al
    Skew in the human caveolin 1 gene upstream purine complex homozygote haplotype compartment in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. ZHANG ZY , Zhang Z, Zug C, Nuesslein-Hildesheim B, et al
    AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. BERG-HANSEN P , Vandvik B, Fagerhol M, Holmoy T, et al
    Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
44. DEB C , Howe CL
    Functional characterization of mouse spinal cord infiltrating CD8+ lymphocytes.
    J Neuroimmunol. 2009;214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. TUMANI H , Pfeifle M, Lehmensiek V, Rau D, et al
    Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid.
    J Neuroimmunol. 2009;214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. KIZELSZTEIN P , Komarnytsky S, Raskin I
    Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. AWAD A , Hemmer B, Hartung HP, Kieseier B, et al
    Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. TACKENBERG B , Schlegel K, Happel M, Eienbroker C, et al
    Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: Novel parallels with thymoma patients.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. SMITH D
    Interferon-beta therapy for multiple sclerosis - Is the injection site the relevant action site?
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. PETERSEN T , Moller-Larsen A, Thiel S, Brudek T, et al
    Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. AHARONI R , Aizman E, Fuchs O, Arnon R, et al
    Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in Experimental Autoimmune Encephalomyelitis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. VANDENBARK AA , Huan J, Agotsch M, La Tocha D, et al
    Interferon-beta-1a treatment increases CD56(bright) natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. LUHDER F , Lee DH, Gold R, Stegbauer J, et al
    Small but powerful: Short peptide hormones and their role in autoimmune inflammation.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. YIN H , Vistica BP, Chan CC, Strominger JL, et al
    Inhibition of experimental autoimmune uveitis by amino acid copolymers.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. SUNDSTROM P , Nystrom M, Ruuth K, Lundgren E, et al
    Antibodies to specific EBNA-1 domains and HLA DRB11501 interact as risk factors for multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
56. DRULOVIC J , Savic E, Pekmezovic T, Mesaros S, et al
    Expression of T(H)1 and T(H)17 cytokines and transcription factors in multiple sclerosis patients: Does baseline T-Bet mRNA predict the response to interferon-beta treatment?
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. TEGLA CA , Cudrici C, Rus V, Ito T, et al
    Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
    J Neuroimmunol. 2009;213.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. BETTINI M , Rosenthal K, Evavold BD
    Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.
    J Neuroimmunol. 2009;213.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. BLASKO E , Haskell CA, Leung S, Gualtieri G, et al
    Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
60. KIM HJ , Jung CG, Dukala D, Bae H, et al
    Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. HAAS J , Korporal M, Balint B, Fritzsching B, et al
    Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. STUBGEN JP
    Recombinant interferon-beta therapy and neuromuscular disorders.
    J Neuroimmunol. 2009;212.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. OGAWA G , Kaida KI, Kusunoki S, Ueda M, et al
    Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barre syndromes.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. CAMERON EM , Spencer S, Lazarini J, Harp CT, et al
    Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. FERNANDES KS , Brum DG, Sandrim VC, Guerreiro CT, et al
    Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. MIROWSKA-GUZEL D , Gromadzka G, Czlonkowski A, Czlonkowska A, et al
    Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. VASCONCELOS CC , Fernandez O, Leyva L, Thuler LC, et al
    Does the DRB11501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. MOSSBERG N , Movitz C, Hellstrand K, Bergstrom T, et al
    Oxygen radical production in leukocytes and disease severity in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    June 2009
69. KIZELSZTEIN P , Ovadia H, Garbuzenko O, Sigal A, et al
    Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. SCHNEIDER C , Schuetz G, Zollner TM
    Acute neuroinflammation in Lewis rats - A model for acute multiple sclerosis relapses.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. TANI T , Sakimura K, Tsujita M, Nakada T, et al
    Identification of binding sites for anti-aquaporin 4 antibodies in patients with neuromyelitis optica.
    J Neuroimmunol. 2009;211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. CHIN CL , Pai M, Bousquet PF, Schwartz AJ, et al
    Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathways.
    J Neuroimmunol. 2009;211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. ROYAL W 3RD , Mia Y, Li H, Naunton K, et al
    Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ELHOFY A , Depaolo RW, Lira SA, Lukacs NW, et al
    Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. CAMINA-TATO M , Morcillo-Suarez C, Navarro A, Fernandez M, et al
    Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. COLASANTI T , Delunardo F, Margutti P, Vacirca D, et al
    Autoantibodies involved in neuropsychiatric manifestations associated with Systemic Lupus Erythematosus.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. COLUMBA-CABEZAS S , Iaffaldano G, Chiarotti F, Alleva E, et al
    Early handling increases susceptibility to experimental autoimmune encephalomyelitis (EAE) in C57BL/6 male mice.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
78. LAPE NIXON M , Matud J, Yeh C, Prince HE, et al
    Evaluation of a multiplex bead-based screening assay for detection of binding antibodies to interferon-beta.
    J Neuroimmunol. 2009;210.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. HATCH MN , Schaumburg CS, Lane TE, Keirstead HS, et al
    Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. BELMAR NA , Lombardo JR, Chao DT, Li O, et al
    Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. AARSKOG NK , Maroy T, Myhr KM, Vedeler CA, et al
    Antibodies against interferon-beta in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. IDIMAN E , Ozakbas S, Dogan Y, Kosehasanogullari G, et al
    The significance of oligoclonal bands in multiple sclerosis: Relevance of demographic and clinical features, and immunogenetic backgrounds.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. ENEVOLD C , Oturai AB, Sorensen PS, Ryder LP, et al
    Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. KAUFFMAN MA , Villa AM
    Comment to Tumour necrosis factor alpha gene -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
85. KAISER CC , Shukla DK, Stebbins GT, Skias DD, et al
    A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. DE ANDRES C , Aristimuno C, Bartolome M, de Las Heras V, et al
    Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4(+) regulatory T-cells in relapsing-remitting multiple sclerosis: A 1-year longitudina
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. VILLAR LM , Masterman T, Casanova B, Gomez-Rial J, et al
    CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. THORNE M , Moore CS, Robertson GS
    Lack of TIMP-1 increases severity of experimental autoimmune encephalomyelitis: Effects of darbepoetin alfa on TIMP-1 null and wild-type mice.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. ERRICHIELLO L , Perruolo G, Pascarella A, Formisano P, et al
    Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. RAMAGOPALAN SV , Morrison KM, Para A, Handel A, et al
    Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. AZOULAY D , Mausner-Fainberg K, Urshansky N, Fahoum F, et al
    Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
92. MUELLER AM , Pedre X, Killian S, David M, et al
    The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
    J Neuroimmunol. 2009;209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. ALMOLDA B , Costa M, Montoya M, Gonzalez B, et al
    CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model.
    J Neuroimmunol. 2009;209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. ROSCOE WA , Welsh ME, Carter DE, Karlik SJ, et al
    VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    J Neuroimmunol. 2009;209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. BRINI E , Ruffini F, Bergami A, Brambilla E, et al
    Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss.
    J Neuroimmunol. 2009;209.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. PERERA D , Stankovich J, Butzkueven H, Taylor BV, et al
    Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
97. MAKAR TK , Bever CT, Singh IS, Royal W, et al
    Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles   
    
    
    
98. ANDREOLI V , Trecroci F, La Russa A, Valentino P, et al
    CASP-9: A susceptibility locus for multiple sclerosis in Italy.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. COMABELLA M , Fernandez-Arquero M, Rio J, Guinea A, et al
    HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. MANA P , Fordham SA, Staykova MA, Correcha M, et al
     Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. CHEN X , Hu X, Zou Y, Pi R, et al
     Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles   
     
     
     March 2009
102. FUHLHUBER V , Bick S, Kirsten A, Hahn A, et al
     Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. DE MASI R , Vergara D, Pasca S, Acierno R, et al
     PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: A pilot study on relation to clinical findings and brain atrophy.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles   
     
     
     
104. GLASS-MARMOR L , Paperna T, Galboiz Y, Miller A, et al
     Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. IMRELL K , Greiner E, Hillert J, Masterman T, et al
     HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles   
     
     
     
106. GORIS A , Dobosi R, Boonen S, Nagels G, et al
     KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. ALSETH EH , Nakkestad HL, Aarseth J, Gilhus NE, et al
     Interleukin-10 promoter polymorphisms in myasthenia gravis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. VANDIEDONCK C , Raffoux C, Eymard B, Tranchant C, et al
     Association of HLA-A in autoimmune myasthenia gravis with thymoma.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. THESSEN HEDREUL M , Gillett A, Olsson T, Jagodic M, et al
     Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
110. FEFERMAN T , Aricha R, Mizrachi K, Geron E, et al
     Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. STUBGEN JP
     Interferon alpha and neuromuscular disorders.
     J Neuroimmunol. 2009;207.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. GAO HX , Campbell SR, Cui MH, Zong P, et al
     Depression is an early disease manifestation in lupus-prone MRL/lpr mice.
     J Neuroimmunol. 2009;207.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. ZIVADINOV R , Weinstock-Guttman B, Zorzon M, Uxa L, et al
     Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. PIGARD N , Elovaara I, Kuusisto H, Paalavuo R, et al
     Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. KHERADMAND T , Wolf NA, Swanborg RH
     Myelin basic protein-reactive T cells persist in an inactive state in the bone marrow of Lewis rats that have recovered from autoimmune encephalomyelitis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. MASSA J , Munger KL, O'Reilly EJ, Levin LI, et al
     Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. LOSONCZI E , Bencsik K, Nagy ZF, Honti V, et al
     Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. PHAM H , Ramp AA, Klonis N, Ng SW, et al
     The astrocytic response in early experimental autoimmune encephalomyelitis occurs across both the grey and white matter compartments.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. BONETTI A , Koivisto K, Pirttila T, Elovaara I, et al
     A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. LI J , Qi H, Tuzun E, Allman W, et al
     Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. KELA-MADAR N , de Rosbo NK, Ronen A, Mor F, et al
     Autoimmune spread to myelin is associated with experimental autoimmune encephalomyelitis induced by a neuronal protein, beta-Synuclein.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
122. LI H , Ciric B, Yang J, Xu H, et al
     Intravenous tolerance modulates macrophage classical activation and antigen presentation in experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. MARUTA T , Yoshikawa H, Fukasawa S, Umeshita S, et al
     Autoantibody to dihydropyridine receptor in myasthenia gravis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. SMOLDERS J , Damoiseaux J, Menheere P, Tervaert JW, et al
     Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. KONG QF , Sun B, Bai SS, Zhai DX, et al
     Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. TAN XD , Dou YC, Shi CW, Duan RS, et al
     Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. AGMON-LEVIN N , Shaye K, Shoenfeld Y
     Neuropsychiatric manifestations of systemic lupus erythematosus - A primary disease manifestation.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles   
     
     
     
128. KRYSTYNA MS , Jacek T, Sebastian R, Ewa B, et al
     Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. DUJMOVIC I , Mangano K, Pekmezovic T, Quattrocchi C, et al
     The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. OSMERS I , Smith SS, Parks BW, Yu S, et al
     Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. YAN J , Greer JM, Etherington K, Cadigan GP, et al
     Immune activation in the peripheral blood of patients with acute ischemic stroke.
     J Neuroimmunol. 2009;206.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. HUANG YC , Lyu RK, Tseng MY, Chang HS, et al
     Decreased intrathecal synthesis of prostaglandin D2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy.
     J Neuroimmunol. 2009;206.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. SULONEN AM , Kallio SP, Ellonen P, Suvela M, et al
     No evidence for shared etiology in two demyelinative disorders, MS and PLOSL.
     J Neuroimmunol. 2009;206.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
134. WANG Y , Evans JT, Rodriguez F, Fields P, et al
     A tale of two STAT6 knock out mice in the induction of experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. LU Z , Hu X, Zhu C, Wang D, et al
     Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
136. HOUFF SA , Berger J, Major EO
     Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
     J Neuroimmunol. 2008;204.
     PubMed     Text format     Related articles   
     
     
     
137. DUGGER KJ , Zinn KR, Weaver C, Bullard DC, et al
     Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
138. PHONGSISAY V , Susuki K, Matsuno K, Yamahashi T, et al
     Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barre syndrome.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. RINTA S , Kuusisto H, Raunio M, Paalavuo R, et al
     Apoptosis-related molecules in blood in multiple sclerosis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. ZEIS T , Kinter J, Herrero-Herranz E, Weissert R, et al
     Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. WEINSTOCK-GUTTMAN B , Bhasi K, Badgett D, Tamano-Blanco M, et al
     Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. NIZRI E , Irony-Tur-Sinai M, Faranesh N, Lavon I, et al
     Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.
     J Neuroimmunol. 2008;203:12-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. CUDRICI C , Ito T, Zafranskaia E, Weerth S, et al
     Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.
     J Neuroimmunol. 2008;203:94-103.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. TOWNSON KH , Speak AO, Greenshields KN, Goodyear CS, et al
     Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury.
     J Neuroimmunol. 2008;203:33-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. FRISULLO G , Nociti V, Iorio R, Patanella AK, et al
     The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. STERNBERG Z , Chadha K, Lieberman A, Hojnacki D, et al
     Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. LINKER RA , Gold R
     Remote changes in gene expression after autoimmune demyelination: Grey matters.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles   
     
     
     
148. KUIJF ML , Geleijns K, Ennaji N, van Rijs W, et al
     Susceptibility to Guillain-Barre syndrome is not associated with CD1A and CD1E gene polymorphisms.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. BENESOVA Y , Vasku A, Stourac P, Hladikova M, et al
     Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. ARISTIMUNO C , Navarro J, de Andres C, Martinez-Gines MA, et al
     Expansion of regulatory CD8(+) T-lymphocytes and fall of activated CD8(+) T-lymphocytes after iv methyl-prednisolone for multiple sclerosis relapse.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
151. MARUSIC S , Thakker P, Pelker JW, Stedman NL, et al
     Blockade of cytosolic phospholipase A(2)alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. BEGUM-HAQUE S , Sharma A, Kasper IR, Foureau DM, et al
     Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. 
     Special issue in memory of John Newsom-Davis.
     J Neuroimmunol. 2008;201-202:1-256.
     PubMed     Text format     Related articles   
     
     
     
154. WILLCOX N
     The legacy of John Newsom-Davis (1932-2007).
     J Neuroimmunol. 2008;201-202:1.
     PubMed     Text format     Related articles   
     
     
     
155. ABAN IB , Wolfe GI, Cutter GR, Kaminski HJ, et al
     The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.
     J Neuroimmunol. 2008;201-202:80-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. STROBEL P , Moritz R, Leite MI, Willcox N, et al
     The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens.
     J Neuroimmunol. 2008;201-202:64-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. MOLENAAR PC
     A relative weak leg muscle in the rolling Nagoya mouse as a model for Lambert-Eaton myasthenic syndrome.
     J Neuroimmunol. 2008;201-202:166-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. BAGGI F , Ubiali F, Nava S, Nessi V, et al
     Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
     J Neuroimmunol. 2008;201-202:104-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. TITULAER MJ , Wirtz PW, Kuks JB, Schelhaas HJ, et al
     The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
     J Neuroimmunol. 2008;201-202:153-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. STUBGEN JP
     B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
161. HAMZAOUI K , Houman H, Hentati F, Hamzaoui A, et al
     BAFF is up-regulated in central nervous system of neuro-Behcet's disease.
     J Neuroimmunol. 2008;200.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. YANG X , Jin T, Press R, Quezada HC, et al
     The expression of TNF-alpha receptors 1 and 2 on peripheral blood mononuclear cells in chronic inflammatory demyelinating polyneuropathy.
     J Neuroimmunol. 2008;200.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. FRANCIOTTA D , Columba-Cabezas S, Andreoni L, Ravaglia S, et al
     Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases.
     J Neuroimmunol. 2008;200.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. MAGGI L , Andreetta F, Antozzi C, Baggi F, et al
     Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. HILL ME , Shiono H, Newsom-Davis J, Willcox N, et al
     The myasthenia gravis thymus: A rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. VINCENT A
     Autoimmune channelopathies: John Newsom-Davis's work and legacy A summary of the Newsom-Davis Memorial Lecture 2008.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. THEIL DJ , Libbey JE, Rodriguez F, Whitton JL, et al
     Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. MATA S , Muscas GC, Naldi I, Rosati E, et al
     Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies.
     J Neuroimmunol. 2008;199.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. MACCIO DR , Fozzatti L, Ditamo Y, Masini-Repiso AM, et al
     Nitric oxide mediates the suppressive effect of testosterone on cell proliferative response to myelin basic protein.
     J Neuroimmunol. 2008;199.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. RIGOLIO R , Biffi A, Oggioni N, Cavaletti G, et al
     Actively induced EAE in Lewis rats: characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease.
     J Neuroimmunol. 2008;199.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. BENNETT JL , Haubold K, Ritchie AM, Edwards SJ, et al
     CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome.
     J Neuroimmunol. 2008;199.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. ALTUNTAS CZ , Daneshgari F, Liu G, Fabiyi A, et al
     Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. PALACIOS R , Comas D, Elorza J, Villoslada P, et al
     Genomic regulation of CTLA4 and Multiple Sclerosis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. CIZERON-CLAIRAC G , Le Panse R, Frenkian-Cuvelier M, Meraouna A, et al
     Thymus and Myasthenia Gravis: What can we learn from DNA microarrays?
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. MOORE CS , Hebb AL, Blanchard MM, Crocker CE, et al
     Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. BLAES F , Pike MG, Lang B
     Autoantibodies in childhood opsoclonus-myoclonus syndrome.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. SANDERS DB , Juel VC
     MuSK-antibody positive myasthenia gravis: Questions from the clinic.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. BRENNER T , Nizri E, Irony-Tur-Sinai M, Hamra-Amitay Y, et al
     Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. KARPUS WJ , Reynolds N, Behanna HA, Van Eldik LJ, et al
     Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. CASCIOLA-ROSEN L , Miagkov A, Nagaraju K, Askin F, et al
     Granzyme B: Evidence for a role in the origin of myasthenia gravis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
181. RAMAGOPALAN SV , Cukjati M, Cernilec M, Deluca GC, et al
     Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. PROUDFOOT AE , de Souza AL, Muzio V
     The use of chemokine antagonists in EAE models.
     J Neuroimmunol. 2008;198.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. ALOISI F , Columba-Cabezas S, Franciotta D, Rosicarelli B, et al
     Lymphoid chemokines in chronic neuroinflammation.
     J Neuroimmunol. 2008;198.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. HAMPTON DW , Anderson J, Pryce G, Irvine KA, et al
     An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. ZISIMOPOULOU P , Lagoumintzis G, Kostelidou K, Bitzopoulou K, et al
     Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. JANSSEN SP , Phernambucq M, Martinez-Martinez P, De Baets MH, et al
     Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. MADDISON P , Lang B
     Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. WILLISON HJ , Halstead SK, Beveridge E, Zitman FM, et al
     The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre syndrome.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. MACLENNAN CA , Vincent A, Marx A, Willcox N, et al
     Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. TAKAMORI M
     Lambert-Eaton myasthenic syndrome: Search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. ILLA I , Diaz-Manera J, Rojas-Garcia R, Pradas J, et al
     Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. WESTALL FC
     A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis"
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles   
     
     
     
193. JUNG C , Stoeckle C, Wiesmuller KH, Laub R, et al
     Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. HOHLFELD R , Wekerle H
     Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
     J Neuroimmunol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. BERZI A , Ayata CK, Cavalcante P, Falcone C, et al
     BDNF and its receptors in human myasthenic thymus: implications for cell fate in thymic pathology.
     J Neuroimmunol. 2008;197:128-39.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. NOTTURNO F , Pace M, De Angelis MV, Caporale CM, et al
     Susceptibility to chronic inflammatory demyelinating polyradiculoneuropathy is associated to polymorphic GA repeat in the SH2D2A gene.
     J Neuroimmunol. 2008;197:124-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
197. MARTIN-MOUTOT N , De Haro L, Seagar M
     Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
     J Neuroimmunol. 2008;197:47-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
198. HAYAKAWA S , Mori M, Okuta A, Kamegawa A, et al
     Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
     J Neuroimmunol. 2008;196.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. SPITSIN S , Portocarrero C, Phares TW, Kean RB, et al
     Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein.
     J Neuroimmunol. 2008;196.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: